title: L-Asparaginase-induced fulminating liver dysfunction.
authors.affiliation: Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Graduate School of Medicine, Kobe, Japan. atsuo@godzilla.kobe-u.ac.jp
authors.forename: Atsuo
authors.initials: A
authors.lastname: Okamura
authors.forename: Meiko
authors.initials: M
authors.lastname: Nishimura
authors.forename: Yukinari
authors.initials: Y
authors.lastname: Sanada
authors.forename: Kimikazu
authors.initials: K
authors.lastname: Yakushijin
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Matsuoka
authors.forename: Katsuya
authors.initials: K
authors.lastname: Yamamoto
authors.forename: Hironobu
authors.initials: H
authors.lastname: Minami
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D001215:Asparaginase / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000503:physiopathology*; D002756:Cholagogues and Choleretics / Q000627:therapeutic use; D016903:Drug Monitoring; D005260:Female; D006801:Humans; D060828:Induction Chemotherapy / Q000009:adverse effects; D015448:Leukemia, B-Cell / Q000188:drug therapy; D008099:Liver / Q000000981:diagnostic imaging / Q000187:drug effects*; D020011:Protective Agents / Q000627:therapeutic use; D011859:Radiography; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D002756:Cholagogues and Choleretics; D020011:Protective Agents; D014580:Ursodeoxycholic Acid; D001215:Asparaginase